SEC Form D private-offering filing
Genialis, Inc.
A new SEC Form D private-offering notice from Boston, MA, a $3,000,000 filer-stated offering target in Biotech. The source filing is one click away.
RNA biomarker company using AI to develop clinically actionable biomarkers for precision oncology
Filed 2025-12-31Filed to raise $3,000,000First money in 2025-12-17Raised so far $700,000HQ (as filed) Boston, MASector Biotech ✓Stage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified genialis.com↗Named in the filing 7 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.